Patent ID: 9199026
Filing Date: 2015-12-01
Classification: A61K,A61M,A61N,A61P,G01N

Abstract:
1. An extracorporeal method for treating a blood-borne disease comprising the steps of: a) removing blood from a subject; b) contacting the blood with an anticoagulant; c) optionally separating the blood into two or more blood fractions; d) modifying the environment of the blood or a blood fraction by deoxygenating the blood or blood fraction; e) treating the blood or blood fraction with a first pharmaceutical agent that is effective in anaerobic conditions; f) modifying the environment of the blood or blood fraction, wherein this second step of modifying the environment does not comprise deoxygenating the blood or blood fraction; g) treating the blood or blood fraction with hydrostatic pressure, a pulsed electrical field, a second pharmaceutical agent, centrifugation, microwave, radiation, sonification, or a combination thereof; and h) returning at least a portion of the blood or blood fraction to the subject.